Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
Welters
Marij J P
MJ
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands. M.J.P.Schoenmaekers-Welters@lumc.nl
van Montfoort
Nadine
N
Khan
Selina
S
Meyer
Ralf G
RG
Britten
Cedrik M
CM
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D017951:Antigen Presentation; D015415:Biomarkers; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005434:Flow Cytometry / Q000379:methods; D005544:Forecasting; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D007167:Immunotherapy / Q000379:methods; D016233:Immunotherapy, Active; D016219:Immunotherapy, Adoptive; D008495:Medical Oncology; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D011323:Primates; D012955:Societies, Medical; D050378:T-Lymphocytes, Regulatory / Q000276:immunology
D000276:Adjuvants, Immunologic; D015415:Biomarkers; D019496:Cancer Vaccines